Company Filing History:
2 out of 68 
1 out of 86 
1 out of 43 Years Active: 2020-2025
Title: Innovations and Contributions of Inventor Shuji Terai
Introduction
Shuji Terai is a notable inventor based in Niigata, Japan. He has made significant contributions to the field of regenerative medicine, particularly in the area of macrophage induction and mesenchymal stem cell activity evaluation. With a total of three patents to his name, Terai's work has the potential to impact therapeutic approaches for various medical conditions.
Latest Patents
Terai's latest patents include an induction method for macrophages, an anti-inflammatory macrophage-inducing agent, and a pharmaceutical composition. The induction method involves culturing macrophages in the presence of exosomes produced from mesenchymal stem cells treated with interferon gamma, leading to the generation of anti-inflammatory macrophages. The anti-inflammatory macrophage-inducing agent comprises these exosomes as an active component. Additionally, Terai has developed a method for evaluating mesenchymal stem cell activity, which includes an assay for adenylate kinase 4 (AK4) levels, and methods for culturing mesenchymal stem cells and producing therapeutic agents for liver dysfunction.
Career Highlights
Throughout his career, Shuji Terai has been associated with prestigious institutions such as Niigata University and Yamaguchi University. His research has focused on advancing the understanding and application of stem cell technology in regenerative medicine.
Collaborations
Terai has collaborated with notable colleagues, including Atsunori Tsuchiya and Suguru Takeuchi, contributing to the advancement of their shared research interests.
Conclusion
Shuji Terai's innovative work in macrophage induction and mesenchymal stem cell evaluation highlights his significant contributions to medical science. His patents reflect a commitment to improving therapeutic strategies for various health conditions.